BioLife Solutions Provides Update On Customer Cell Therapy Clinical Trials And Development Programs

BioLife Solutions, Inc. (NASDAQ: BLFS), a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage andcryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers, today provided an update on several customer clinical trials and development programs using cellular therapies and cellular immunotherapies in human regenerative medicine applications.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news